gold has been researched along with as 1411 in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 6 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X; Liu, Z; Pu, F; Qu, X; Ren, J; Yang, X | 1 |
| Ai, J; Li, D; Lou, B; Wang, E; Xu, Y | 1 |
| Culver, KS; Dam, DH; Odom, TW | 1 |
| Celli, A; Garcimartín, Y; Latorre, A; Ma, J; Ortiz-Urda, S; Posch, C; Rappersberger, K; Sanlorenzo, M; Somoza, Á; Vujic, I; Zekhtser, M | 1 |
| Chiu, HH; Huang, YF; Shiao, YS; Wu, PH | 1 |
| Bardi, GT; Bates, PJ; Casson, LK; Kang, KA; Malik, MT; Ng, CK; O'Toole, MG; Reyes-Reyes, EM; Thomas, SD | 1 |
| Cai, S; Chen, D; Chen, H; Gu, Y; He, Y; Li, B; Peng, S; Sheng, Y; Wang, P | 1 |
| Deng, R; Liu, S; Meguellati, K; Shen, N; Xu, S; Yan, F; Yang, Y; Yang, YW; Yu, H | 1 |
| Jiang, JH; Li, N; Liu, JW; Tang, H; Xiang, MH | 1 |
| Cui, YX; Du, YC; Kong, DM; Li, XY; Sun, GY; Tang, AN; Wang, J | 1 |
| Baneshi, M; Bardania, H; Dadfarnia, S; Haghgoo, S; Sabbagh, SK; Shabani, AMH | 1 |
| Bouvet, P; Chalabi-Dchar, M; Diaz, JJ; Kabirian-Dehkordi, S; Le Guellec, D; Mehrgardi, MA; Mertani, HC; Verrier, B | 1 |
| Alibakhshi, A; Kardani, A; Khatami, M; Yaghoobi, H | 1 |
| Del Valle, AC; Huang, YF; Su, CK; Sun, YC | 1 |
| Nie, L; Sun, M; Sun, S; Wang, L; Zhang, Z; Zheng, L; Zhou, Q | 1 |
| Arbabi, A; Hashemi, B; Mehrnia, SS; Mowla, SJ; Nikkhah, M | 1 |
| Cheng, J; Cui, D; de la Fuente, JM; Ding, X; Han, Y; Jin, W; Liu, Y; Ni, J; Song, J; Sun, Q; Wang, X; Yang, Y; Yue, C | 1 |
| Jou, AF; Su, ZY; Yang, BZ | 1 |
18 other study(ies) available for gold and as 1411
| Article | Year |
|---|---|
Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles.
Topics: Animals; Apoptosis; Aptamers, Nucleotide; Cell Line, Tumor; Drug Carriers; Fluorescein-5-isothiocyanate; Gold; Humans; Infrared Rays; Mice; Nanotubes; NIH 3T3 Cells; Oligodeoxyribonucleotides; Porosity; Silicon Dioxide | 2012 |
Multifunctional AS1411-functionalized fluorescent gold nanoparticles for targeted cancer cell imaging and efficient photodynamic therapy.
Topics: Aptamers, Nucleotide; Cell Proliferation; Female; Fluorescent Dyes; Gold; Humans; Light; Metal Nanoparticles; Oligodeoxyribonucleotides; Photochemotherapy; Protoporphyrins; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2014 |
Grafting aptamers onto gold nanostars increases in vitro efficacy in a wide range of cancer cell types.
Topics: Aptamers, Nucleotide; Cell Line; Cell Line, Tumor; Down-Regulation; Drug Delivery Systems; Genes, bcl-2; Gold; Humans; Metal Nanoparticles; Neoplasms; Nucleolin; Oligodeoxyribonucleotides; Phosphoproteins; RNA-Binding Proteins | 2014 |
DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics.
Topics: Antineoplastic Agents; Aptamers, Nucleotide; Cell Line, Tumor; Cell Survival; DNA; Doxorubicin; Drug Carriers; Gold; Humans; MCF-7 Cells; Metal Nanoparticles; Microscopy, Confocal; Morpholines; Oligodeoxyribonucleotides | 2014 |
Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery.
Topics: Antineoplastic Agents; Aptamers, Nucleotide; Base Sequence; Drug Carriers; Gold; HeLa Cells; Humans; MCF-7 Cells; Metal Nanoparticles; Oligodeoxyribonucleotides | 2014 |
AS1411-conjugated gold nanospheres and their potential for breast cancer therapy.
Topics: Animals; Aptamers, Nucleotide; Breast Neoplasms; Cell Line, Tumor; Female; Gold; Humans; MCF-7 Cells; Metal Nanoparticles; Mice; Mice, Nude; Nanospheres; Oligodeoxyribonucleotides; Random Allocation; Xenograft Model Antitumor Assays | 2015 |
Dual targeting luminescent gold nanoclusters for tumor imaging and deep tissue therapy.
Topics: Animals; Antibiotics, Antineoplastic; Aptamers, Nucleotide; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Female; Gold; Humans; Luminescent Agents; Metal Nanoparticles; Mice, Nude; Microscopy, Confocal; Nanoconjugates; Neoplasms; Oligodeoxyribonucleotides; Peptides, Cyclic | 2016 |
Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy.
Topics: Animals; Antagomirs; Aptamers, Nucleotide; Cell Line, Tumor; DNA Methylation; Drug Carriers; Epigenesis, Genetic; Genetic Therapy; Gold; Humans; Leukemia, Myeloid, Acute; Male; Metal Nanoparticles; Mice, Inbred C57BL; MicroRNAs; Nuclear Localization Signals; Oligodeoxyribonucleotides | 2018 |
DNA Polymer Nanoparticles Programmed via Supersandwich Hybridization for Imaging and Therapy of Cancer Cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Aptamers, Nucleotide; Chlorophyllides; DNA; Doxorubicin; Drug Carriers; Drug Liberation; Female; Fluorescence; Gold; HeLa Cells; Humans; Light; Metal Nanoparticles; Microscopy, Confocal; Nucleic Acid Hybridization; Oligodeoxyribonucleotides; Photosensitizing Agents; Porphyrins; Singlet Oxygen; Theranostic Nanomedicine; Uterine Cervical Neoplasms | 2018 |
Terminal Deoxynucleotidyl Transferase-Catalyzed Preparation of pH-Responsive DNA Nanocarriers for Tumor-Targeted Drug Delivery and Therapy.
Topics: Animals; Aptamers, Nucleotide; Delayed-Action Preparations; DNA Adducts; DNA Nucleotidylexotransferase; Doxorubicin; Female; Gold; HeLa Cells; Humans; Hydrogen-Ion Concentration; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; NIH 3T3 Cells; Oligodeoxyribonucleotides; Xenograft Model Antitumor Assays | 2019 |
A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery.
Topics: Antineoplastic Agents; Apoptosis; Aptamers, Nucleotide; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Drug Liberation; Ferric Compounds; Gold; Humans; Nanoparticles; Oligodeoxyribonucleotides; Serum Albumin, Bovine; Theranostic Nanomedicine | 2019 |
AS1411-conjugated gold nanoparticles affect cell proliferation through a mechanism that seems independent of nucleolin.
Topics: Aptamers, Nucleotide; Cell Cycle Checkpoints; Cell Line, Tumor; Down-Regulation; Gold; Humans; Metal Nanoparticles; Nucleolin; Oligodeoxyribonucleotides; Phosphoproteins; RNA-Binding Proteins; RNA, Ribosomal | 2019 |
Inhibition of miR-155 in MCF-7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer.
Topics: Animals; Antagomirs; Apoptosis; Aptamers, Nucleotide; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetulus; Drug Delivery Systems; Female; Gold; Humans; MCF-7 Cells; Metal Nanoparticles; MicroRNAs; Oligodeoxyribonucleotides | 2020 |
NIR-cleavable drug adducts of gold nanostars for overcoming multidrug-resistant tumors.
Topics: Administration, Intravenous; Animals; Antineoplastic Agents; Aptamers, Nucleotide; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Female; Gold; Humans; MCF-7 Cells; Metal Nanoparticles; Mice; Nucleolin; Oligodeoxyribonucleotides; Phosphoproteins; RNA-Binding Proteins; Xenograft Model Antitumor Assays | 2020 |
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery.
Topics: A549 Cells; Aptamers, Nucleotide; Chemistry Techniques, Synthetic; Doxorubicin; Drug Carriers; Gold; Humans; Metal Nanoparticles; Oligodeoxyribonucleotides; Polyethylene Glycols; Polyethyleneimine | 2020 |
Radiosensitization of breast cancer cells using AS1411 aptamer-conjugated gold nanoparticles.
Topics: Antineoplastic Agents; Apoptosis; Aptamers, Nucleotide; Breast Neoplasms; Cell Proliferation; Electrons; Female; Gold; Humans; Metal Nanoparticles; Oligodeoxyribonucleotides; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 2021 |
Au-siRNA@ aptamer nanocages as a high-efficiency drug and gene delivery system for targeted lung cancer therapy.
Topics: Animals; Aptamers, Nucleotide; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Delivery Systems; Gene Transfer Techniques; Gold; Lung; Lung Neoplasms; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Oligodeoxyribonucleotides; Particle Size; RNA, Small Interfering; Survival Rate | 2021 |
Exploiting the Catalytic Ability of Polydopamine-Remodeling Gold Nanoparticles toward the Naked-Eye Detection of Cancer Cells at a Single-Cell Level.
Topics: Animals; Aptamers, Nucleotide; Biocompatible Materials; Biosensing Techniques; Breast Neoplasms; Catalysis; Cattle; Cells, Cultured; Gold; Humans; Indoles; Materials Testing; Metal Nanoparticles; Molecular Structure; Nucleolin; Oligodeoxyribonucleotides; Particle Size; Phosphoproteins; Polymers; RNA-Binding Proteins; Serum Albumin, Bovine; Single-Cell Analysis | 2021 |